SMTL ID : 8sce.3 (3 other biounits)

Crystal structure of IRAK4-HSA complexed with N-[(2R)-2-FLUORO-3-HYDROXY-3-METHYLBUTYL]-6-[(5-FLUOROPYRI-YL)AMINO]-4-[(PROPAN-2-YL)AMINO]PYRIDINE-3-CARBOXAMIDE

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: D.267, S.268 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.268, A:S.268, A:S.268

1 x ZVD: N-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-[(5-fluoropyrimidin-4-yl)amino]-4-[(propan-2-yl)amino]pyridine-3-carboxamide(Non-covalent)

ZVD.2: 20 residues within 4Å: Chain A: M.37, G.38, E.39, V.45, A.56, V.91, Y.107, V.108, Y.109, M.110, P.111, N.112, G.113, S.114, D.117, R.118, D.123, T.125, L.163, S.173 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.45, A:T.125 Hydrogen bonds: A:M.37, A:V.108, A:Y.109, A:M.110, A:M.110, A:G.113 Water bridges: A:K.58, A:S.114, A:S.114, A:R.118, A:S.173 pi-Stacking: A:Y.107

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kumar, S.R. et al., The Discovery of IRAK4 Inhibitor Clinical Candidates BMS-986126 and BMS-986147 for the Treatment of Autoimmune Diseases. To Be Published

Release Date

2025-02-12

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence